• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝移植受者的长期预后(5 年以上)——一项跨大西洋多中心研究。

Long-term outcomes (beyond 5 years) of liver transplant recipients-A transatlantic multicenter study.

机构信息

NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, UK.

Nottingham Digestive Diseases Centre, Translational Medical Sciences, School of Medicine, University of Nottingham, UK.

出版信息

Liver Transpl. 2024 Feb 1;30(2):170-181. doi: 10.1097/LVT.0000000000000244. Epub 2023 Aug 18.

DOI:10.1097/LVT.0000000000000244
PMID:37589505
Abstract

The long-term (>5 y) outcomes following liver transplantation (LT) have not been extensively reported. The aim was to evaluate outcomes of LT recipients who have survived the first 5 years. A multicenter retrospective analysis of prospectively collected data from 3 high volume LT centers (Dallas-USA, Birmingham-UK, and Barcelona-Spain) was undertaken. All adult patients, who underwent LT since the inception of the program to December 31, 2010, and survived at least 5 years since their LT were included. Patient survival was the primary outcome. A total of 3682 patients who survived at least 5 years following LT (long-term survivors) were included. Overall, median age at LT was 52 years (IQR 44-58); 53.1% were males; and 84.6% were Caucasians. A total of 49.4% (n=1820) died during a follow-up period of 36,828 person-years (mean follow-up 10 y). A total of 80.2% (n=1460) of all deaths were premature deaths. Age-standardized all-cause mortality as compared to general population was 3 times higher for males and 5 times higher for females. On adjusted analysis, besides older recipients and older donors, predictors of long-term mortality were malignancy, cardiovascular disease, and dialysis. Implementation of strategies such as noninvasive cancer screening, minimizing immunosuppression, and intensive primary/secondary cardiovascular prevention could further improve survival.

摘要

肝移植(LT)后 5 年以上的长期结果尚未广泛报道。本研究旨在评估存活超过 5 年的 LT 受者的结局。采用多中心回顾性分析方法,对 3 个大容量 LT 中心(美国达拉斯、英国伯明翰和西班牙巴塞罗那)前瞻性收集的数据进行分析。纳入自项目启动至 2010 年 12 月 31 日期间接受 LT 且 LT 后至少存活 5 年的所有成年患者。患者生存是主要结局。共纳入 3682 例 LT 后至少存活 5 年(长期存活者)的患者。总体而言,LT 时的中位年龄为 52 岁(四分位距 44-58);53.1%为男性;84.6%为白种人。在 36828 人年的随访期间(平均随访 10 年),共有 1820 例(49.4%)患者死亡。所有死亡中,共有 1460 例(80.2%)为过早死亡。与普通人群相比,男性全因死亡率的年龄标准化比值为 3 倍,女性为 5 倍。在调整分析中,除了年龄较大的受者和供者外,恶性肿瘤、心血管疾病和透析也是长期死亡的预测因素。实施非侵入性癌症筛查、最小化免疫抑制和强化原发性/继发性心血管预防等策略可能会进一步提高生存率。

相似文献

1
Long-term outcomes (beyond 5 years) of liver transplant recipients-A transatlantic multicenter study.肝移植受者的长期预后(5 年以上)——一项跨大西洋多中心研究。
Liver Transpl. 2024 Feb 1;30(2):170-181. doi: 10.1097/LVT.0000000000000244. Epub 2023 Aug 18.
2
Incidence, Predictors, and Impact on Survival of Long-term Cardiovascular Events After Liver Transplantation.肝移植后长期心血管事件的发生率、预测因素及其对生存的影响。
Transplantation. 2020 Feb;104(2):317-325. doi: 10.1097/TP.0000000000002852.
3
Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study.肝移植后死亡率的病因和风险因素的演变:NIDDK 长期随访研究的结果。
Am J Transplant. 2010 Jun;10(6):1420-7. doi: 10.1111/j.1600-6143.2010.03126.x. Epub 2010 May 10.
4
Evaluation of Early Allograft Function Using the Liver Graft Assessment Following Transplantation Risk Score Model.利用移植后风险评分模型评估肝移植物早期功能。
JAMA Surg. 2018 May 1;153(5):436-444. doi: 10.1001/jamasurg.2017.5040.
5
Long-term outcome of 'long-term liver transplant survivors'.“长期肝移植存活者”的长期预后。
Transpl Int. 2013 Jul;26(7):740-50. doi: 10.1111/tri.12118. Epub 2013 May 28.
6
Cardiovascular morbidity and mortality is increased post-liver transplantation even in recipients with no pre-existing risk factors.即使在没有预先存在的风险因素的肝移植受者中,肝移植后心血管发病率和死亡率也会增加。
Liver Int. 2019 Aug;39(8):1557-1565. doi: 10.1111/liv.14185. Epub 2019 Jul 10.
7
Cardiovascular morbidity and mortality after liver transplantation: The protective role of mycophenolate mofetil.肝移植后心血管疾病的发病率和死亡率:霉酚酸酯的保护作用。
Liver Transpl. 2017 Apr;23(4):498-509. doi: 10.1002/lt.24738.
8
Framingham score, renal dysfunction, and cardiovascular risk in liver transplant patients.弗雷明汉评分、肾功能不全与肝移植患者的心血管风险
Liver Transpl. 2015 Jun;21(6):812-22. doi: 10.1002/lt.24128.
9
Analysis of adult 20-year survivors after liver transplantation.肝移植术后成年20年幸存者的分析。
Hepatol Int. 2015 Jul;9(3):461-70. doi: 10.1007/s12072-014-9577-x. Epub 2014 Sep 18.
10
Troponin I Is Not a Predictor of Early Cardiovascular Morbidity in Liver Transplant Recipients.肌钙蛋白I并非肝移植受者早期心血管疾病发病率的预测指标。
Transplant Proc. 2018 Sep;50(7):2022-2026. doi: 10.1016/j.transproceed.2018.02.136. Epub 2018 Mar 14.

引用本文的文献

1
Long-Term Prognostic Value of AFP and PIVKA-II in HCC After Living Donor Liver Transplantation: A Single-Center Retrospective Study.甲胎蛋白和异常凝血酶原在活体肝移植后肝癌中的长期预后价值:一项单中心回顾性研究
Transpl Int. 2025 Jun 27;38:14748. doi: 10.3389/ti.2025.14748. eCollection 2025.
2
Liver transplantation for HBV-related liver disease: Impact of prophylaxis for HBV on HCC recurrence.乙型肝炎病毒相关肝病的肝移植:乙肝预防对肝癌复发的影响。
JHEP Rep. 2024 Nov 23;7(3):101278. doi: 10.1016/j.jhepr.2024.101278. eCollection 2025 Mar.
3
Aging with a Liver Graft: Analysis of Very Long-Term Survivors after Liver Transplantation.
肝脏移植后的衰老:肝移植术后长期存活者分析
J Clin Med. 2024 Feb 14;13(4):1087. doi: 10.3390/jcm13041087.